ECO Animal Health Group plc (AIM:EAH)

ECO Animal Health Group Financials Overview

Financials in millions GBP. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	87.53	87.53	79.6	89.42	85.31	82.2
Revenue Growth	1.99%	9.96%	-10.99%	4.82%	3.79%	-22.17%
Gross Profit Gross Profit Growth	42.5	42.5	35.91	37.68	38.38	35.14
Operating Income Operating Income Growth	5.72	5.72	3.35	4.19	4.95	3.53
Net Income Net Income Growth	2.19	2.19	1.69	1.05	1.01	-0.69
Earnings Per Share EPS Growth	0.03	0.03	0.02	0.02	0.01	-0.01
EPS Growth	-27.44%	29.63%	59.87%	3.40%	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Corporate/U.K. Corporate/U.K. Growth	1.21	1.21	1.11	0.93	1.3	1.53
China and Japan China and Japan Growth	24.06	24.06	22.9	24.66	26.37	28.39
North America (USA and Canada) North America (USA and Canada) Growth	26.15	26.15	21.41	18.48	15.17	16.4
South and South East Asia South and South East Asia Growth	11.08	11.08	11.85	17.44	16.76	11.82
Latin America Latin America Growth	18.81	18.81	16.31	19.89	18.11	15.78
Europe Europe Growth	4.8	4.8	4.91	6.45	6.07	6.43
Rest of the World Rest of the World Growth	1.43	1.43	1.1	1.58	1.52	1.86
Total Total Growth	87.53	87.53	79.6	89.42	85.31	82.2

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	25.43	25.43	25.01	22.37	21.66	14.31
Total Debt Total Debt Growth	4.93	4.93	3.79	4.03	4.48	1.91
Net Cash (Debt) Net Cash Growth	20.5	20.5	21.22	18.35	17.18	12.4
Net Cash Growth	51.03%	-3.40%	15.65%	6.82%	38.49%	-31.09%
Net Cash Per Share Net Cash Per Share Growth	0.29	0.29	0.31	0.27	0.25	0.18

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	7.66	7.66	10.45	9.42	15.91	-0.55
Capital Expenditures CapEx Growth	-0.19	-0.19	-0.36	-0.5	-3.56	-1.62
Free Cash Flow Free Cash Flow Growth	7.46	7.46	10.09	8.92	12.34	-2.17
Free Cash Flow Growth	-12.99%	-26.05%	13.20%	-27.78%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	48.55%	48.55%	45.12%	42.14%	44.98%	42.75%
Operating Margin	6.53%	6.53%	4.21%	4.68%	5.80%	4.29%
Pretax Margin	6.21%	6.21%	5.04%	3.33%	5.20%	1.69%
Profit Margin	2.50%	2.50%	2.12%	1.17%	1.18%	-0.83%
FCF Margin	8.53%	8.53%	12.68%	9.97%	14.47%	-2.64%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	31.75	29.70	21.50	55.27	64.83	-
Forward PE	26.56	32.22	30.40	32.02	30.64	30.22
P/FCF Ratio	9.08	8.72	3.59	6.50	5.29	-
PS Ratio	0.77	0.74	0.46	0.65	0.77	1.34

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error